ZTS (Zoetis Inc) Enterprise Value to Sales Volume

zoetis.com (ZTS) - corporate logo

On the GURU.Markets platform, the EV/Sales ratio visualizes the market revaluation of Zoetis Inc. (ZTS), where 4262.76 records a new level. Innovative arthritis medications and the trend toward pet humanization are driving this growth. A global network of R&D centers ensures supply reliability. Due to the low price elasticity of veterinary services, Zoetis Inc. (ZTS) maintains high margins regardless of the overall economic cycle.

ZTS (Zoetis Inc.) Enterprise Value-to-Revenue Ratio history from 11/23/2025 to 11/20/2026

zoetis.com - analytical breakdowns and key metrics (ZTS)

- market price and analyst price targets:
Fundamental valuation:zoetis.com (ZTS)
Brand item of Zoetis Inc.

When screening issuer reliability, it is essential to determine the fair value of the business by excluding the impact of debt load. Evaluating a firm using the EV/Sales multiple compares the total enterprise value to sales volume, making it possible to identify if an asset is overbought relative to its actual operational capacities. For Zoetis Inc. (ZTS), this indicator reflects the market premium for the high margins of veterinary vaccines and pharmaceuticals, signaling potential trend reversals.